We have participated in the PrecisonMed 2023 conference in Dubai, where we were exhibiting our comprehensive portfolio of genetic services with a key focus on the WGS based myGemone analysis.

The exhibition provides a unique opportunity for those developing personalized healthcare solutions from across the globe to do business with the key healthcare decision-makers in the Gulf and Middle East region.

Madrid, May 29, 2023

Veritas has participated in PrecisionMed Exhibition & Summit 2023, held in Dubai from May 23^rd to 24^th , where the latest updates were shared in various areas of genomic research.

The PrecisionMed brought together more than 5000 visitors and 100 exhibitors, among them recognized leaders, top global researchers, medical professionals, and innovators across healthcare and biotechnology sectors.

Genomics has become a key tool in preventive medicine and Veritas pioneered genome sequencing and interpretation for preventive purposes. Additionally, it has developed a variety of specific panels related to specific pathologies, in areas such as oncology and cardiology.

Growing populations, rising life expectancy and changes in lifestyle are leaving a healthcare burden for governments in the Gulf region, they have an urgent need to find smart approaches to tackle the medical needs of their populations. The preventive, predictive and precision medicine that Veritas promotes through its genetic services is undoubtedly an essential part that healthcare systems will be implementing over the coming years, anticipating the problem is undoubtedly a fundamental part of the solution.

About Veritas

At Veritas, we apply science and our global resources to bring genetic and genomic diagnostics to people to extend and significantly improve their lives. Our global portfolio includes preventive medicine, perinatal medicine, and genomic diagnostic services.

In March 2022 Veritas announced that it was becoming part of LetsGetChecked, a global healthcare solutions company based in Dublin and New York.

In keeping with our responsibility as a leading biotechnology company, we collaborate with healthcare providers, governments, and local communities to support and expand access to genetic and genomic medicine reliably and affordably around the world.